A Covalent Inhibitor for Glutathione S-Transferase Pi (GSTP

Amino Acid Sequence Binding Sites / drug effects Cell Line, Tumor Enzyme Inhibitors / chemical synthesis Glutathione / analogs & derivatives Glutathione S-Transferase pi / antagonists & inhibitors Humans Molecular Docking Simulation Sulfones / chemical synthesis Tyrosine / chemistry
antitumor agents covalent inhibitors glutathione S-transferase irreversible inhibitors sulfonyl fluoride

Journal

Chembiochem : a European journal of chemical biology
ISSN: 1439-7633
Titre abrégé: Chembiochem
Pays: Germany
ID NLM: 100937360

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 03 11 2018
pubmed: 15 12 2018
medline: 8 1 2020
entrez: 15 12 2018
Statut: ppublish

Résumé

Glutathione S-transferase π (GSTP

Identifiants

DOI: 10.1002/cbic.201800671 PMID: 30548113
pubmed: 30548113
doi: 10.1002/cbic.201800671
doi:

Substances chimiques

Enzyme Inhibitors 0
Sulfones 0
Tyrosine 42HK56048U
GSTP1 protein, human EC 2.5.1.18
Glutathione S-Transferase pi EC 2.5.1.18
Glutathione GAN16C9B8O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

900-905

Informations de copyright

© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Yuko Shishido (Y)

Graduate School of Science, Nagoya University, Furo-cho, Chikusa-Ku, Nagoya, Aichi, 464-8602, Japan.
Faculty of Pharmaceutical Science, Hokkaido University, Kita-12, Nishi-6, Kita-Ku, Sapporo, Hokkaido, 060-0812, Japan.
ORCID: 0000-0001-6324-5708

Fumiaki Tomoike (F)

Research Center for Materials Science, Nagoya University, Furo-cho, Chikusa-Ku, Nagoya, Aichi, 464-8602, Japan.
ORCID: 0000-0003-2724-2272

Keiko Kuwata (K)

Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, Furo-cho, Chikusa-Ku, Nagoya, Aichi, 464-8602, Japan.

Haruka Fujikawa (H)

Graduate School of Science, Nagoya University, Furo-cho, Chikusa-Ku, Nagoya, Aichi, 464-8602, Japan.

Yoshitaka Sekido (Y)

Division of Cancer Biology, Aichi Cancer Center Research Institute, 1-1, Kanokoden, Chikusa-Ku, Nagoya, Aichi, 464-8681, Japan.

Yuko Murakami-Tonami (Y)

Division of Cancer Biology, Aichi Cancer Center Research Institute, 1-1, Kanokoden, Chikusa-Ku, Nagoya, Aichi, 464-8681, Japan.
Juntendo University, Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Tomoshi Kameda (T)

Artificial Intelligence Research Center, National Institute of Advanced Industrial Science and Technology, 2-4-7, Aomi, Ko-to-ku, Tokyo, 135-0064, Japan.

Naoko Abe (N)

Graduate School of Science, Nagoya University, Furo-cho, Chikusa-Ku, Nagoya, Aichi, 464-8602, Japan.

Yasuaki Kimura (Y)

Graduate School of Science, Nagoya University, Furo-cho, Chikusa-Ku, Nagoya, Aichi, 464-8602, Japan.

Satoshi Shuto (S)

Faculty of Pharmaceutical Science, Hokkaido University, Kita-12, Nishi-6, Kita-Ku, Sapporo, Hokkaido, 060-0812, Japan.

Hiroshi Abe (H)

Graduate School of Science, Nagoya University, Furo-cho, Chikusa-Ku, Nagoya, Aichi, 464-8602, Japan.
ORCID: 0000-0003-0048-3789

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Sciences de l'information › Sources d'information › Services d'information › Documentation › Données de séquences moléculaires › Séquence d'acides aminés › A Covalent Inhibitor for Glutathione...
questionsmedicales.fr › Phénomènes chimiques › Phénomènes biochimiques › Sites de fixation › A Covalent Inhibitor for Glutathione...
questionsmedicales.fr › Cellules › Cellules cultivées › Cellules cancéreuses en culture › Lignée cellulaire tumorale › A Covalent Inhibitor for Glutathione...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › A Covalent Inhibitor for Glutathione...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Oligopeptides › Glutathion › A Covalent Inhibitor for Glutathione...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Transferases › Alkyl et aryl transferases › Glutathione transferase › Glutathione S-transferase pi › A Covalent Inhibitor for Glutathione...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A Covalent Inhibitor for Glutathione...
questionsmedicales.fr › Sciences de l'information › Méthodologies informatiques › Simulation numérique › Simulation de docking moléculaire › A Covalent Inhibitor for Glutathione...
questionsmedicales.fr › Composés chimiques organiques › Composés du soufre › Sulfones › A Covalent Inhibitor for Glutathione...
questionsmedicales.fr › Acides aminés, peptides et protéines › Acides aminés › Acides aminés cycliques › Acides aminés aromatiques › Tyrosine › A Covalent Inhibitor for Glutathione...